Abstract
Major congenital anomalies (MCAs) are defined as those which are lethal and/or which cause major handicaps and/or which require surgery. While the general population risk for having a baby with an MCA is one to three percent, that for a woman who has pregestational diabetes mellitus is three to six times as great. Fetal organogenesis takes place from the fifth to the eighth post-menstrual weeks. A body of evidence suggests that maternal hyperglycemia early in gestation is either contributory to fetal teratogenesis or is a surrogate marker for the causative agent of MCAs in infants of diabetic mothers. Given that organogenesis begins at the time of a womans first recognition of pregnancy, and given the one or more weeks thereafter needed to establish prenatal care, it is essential that the woman who has diabetes attempt to lower her glucose concentrations and treat any intercurrent complications (e.g. hypertension, retinopathy) prior to the initiation of efforts to conceive. The elements of a preconception care program for pregestational diabetic women include health care provider education, patient recruitment and retention, education about family planning and distribution of contraception, the diagnosis and treatment of complications of diabetes, the establishment of control of maternal glucose, and the transition to intensive prenatal care. The support and encouragement of health care personnel, family, and friends is essential for patient retention and compliance with the often rigorous demands of good preconception care.
Keywords: Diabetes, Pregnancy, Birth Defects, Preconception Care
Current Diabetes Reviews
Title: Preconception Care for Diabetic Women: Background, Barriers, and Strategies for Effective Implementation
Volume: 2 Issue: 2
Author(s): David A. Sacks
Affiliation:
Keywords: Diabetes, Pregnancy, Birth Defects, Preconception Care
Abstract: Major congenital anomalies (MCAs) are defined as those which are lethal and/or which cause major handicaps and/or which require surgery. While the general population risk for having a baby with an MCA is one to three percent, that for a woman who has pregestational diabetes mellitus is three to six times as great. Fetal organogenesis takes place from the fifth to the eighth post-menstrual weeks. A body of evidence suggests that maternal hyperglycemia early in gestation is either contributory to fetal teratogenesis or is a surrogate marker for the causative agent of MCAs in infants of diabetic mothers. Given that organogenesis begins at the time of a womans first recognition of pregnancy, and given the one or more weeks thereafter needed to establish prenatal care, it is essential that the woman who has diabetes attempt to lower her glucose concentrations and treat any intercurrent complications (e.g. hypertension, retinopathy) prior to the initiation of efforts to conceive. The elements of a preconception care program for pregestational diabetic women include health care provider education, patient recruitment and retention, education about family planning and distribution of contraception, the diagnosis and treatment of complications of diabetes, the establishment of control of maternal glucose, and the transition to intensive prenatal care. The support and encouragement of health care personnel, family, and friends is essential for patient retention and compliance with the often rigorous demands of good preconception care.
Export Options
About this article
Cite this article as:
Sacks A. David, Preconception Care for Diabetic Women: Background, Barriers, and Strategies for Effective Implementation, Current Diabetes Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339906776818587
DOI https://dx.doi.org/10.2174/157339906776818587 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science The Role of Vitamin D in Atherosclerosis Inflammation Revisited: More a Bystander than a Player?
Current Vascular Pharmacology Biomarkers Associated with Stroke Risk in Atrial Fibrillation
Current Medicinal Chemistry Targeted Metabolomics Reveals Hippurate as a Urinary Potential Marker for Diabetic Nephropathy
Current Metabolomics Maternal Nutrition and Predisposition to Later Kidney Disease
Current Drug Targets The Long Term Biological Consequences of Anorexia Nervosa
Current Nutrition & Food Science Effects of Liver Diseases on Drug-metabolizing Enzymes: Implications for Drug Fate Alterations and Nano-therapeutic Openings
Current Medicinal Chemistry Combination of a Sterol Absorption Inhibitor and Cardiovascular Agents for the Treatment of Dyslipidemia
Recent Patents on Cardiovascular Drug Discovery The Soluble CTLA-4 Receptor and its Emerging Role in Autoimmune Diseases
Current Immunology Reviews (Discontinued) Ribosome Inactivating Proteins (RIPs) from Momordica charantia for Anti Viral Therapy
Current Molecular Medicine Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets <i>In vitro</i>, <i>In vivo</i> and <i>In silico</i> Antihyperglycemic Activity of Some Semi-Synthetic Phytol Derivatives
Medicinal Chemistry The Adiponectin Signaling Pathway as a Novel Pharmacological Target
Mini-Reviews in Medicinal Chemistry The Role of CTLA-4 Gene Polymorphisms in Autoimmune Disease Pathogenesis: A 2012 Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Microparticles: From Biogenesis to Biomarkers and Diagnostic Tools in Cardiovascular Disease
Current Stem Cell Research & Therapy Role of Antioxidants, Essential Fatty Acids, Carnitine, Vitamins, Phytochemicals and Trace Elements in the Treatment of Diabetes Mellitus and its Chronic Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets Subject Index To Volume 6
Endocrine, Metabolic & Immune Disorders - Drug Targets Toll-Like Receptor 4 and Heat-Shock Protein 70: Is it a New Target Pathway for Diabetic Vasculopathies?
Current Drug Targets Gender Differences in the Treatment of Ischemic Heart Disease
Current Pharmaceutical Design